This paper is in the following e-collection/theme issue:

Participatory Research Protocols and Proposals (142) Precision Medicine (78) Infectious Diseases (non-STD/STI) (1584) Influenza and Influenza-Like-Illness (ILI) Surveillance (218) Clinical Information and Decision Making (1423)

Published on in Vol 13 (2024)

This is a member publication of University of Oxford (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/56271, first published .
Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study

Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study

Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study

Authors of this article:

Meredith Leston1 Author Orcid Image ;   José Ordóñez-Mena1 Author Orcid Image ;   Mark Joy1 Author Orcid Image ;   Simon de Lusignan1 Author Orcid Image ;   Richard Hobbs1 Author Orcid Image ;   Iain McInnes2 Author Orcid Image ;   Lennard Lee3 Author Orcid Image
Article Authors Cited by (1) Tweetations (4) Metrics

Journals

  1. Leston M, Kar D, Forbes A, Jamie G, Wimalaratna R, Jiwani G, Ordóñez-Mena J, Stewart D, Whitaker H, Joy M, Lee L, Hobbs F, de Lusignan S. Developing a digital phenotype to subdivide adult immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network. Frontiers in Immunology 2024;15 View